Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-28

Clinical Trial Update: The Effects of Non-invasive Neuromodulation on Illness Awareness in Schizophrenia [NA]

View source ↗

Summary

The clinical trial evaluating non-invasive neuromodulation to improve illness awareness in schizophrenia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Schizophrenia, Anosognosia | NA | Status: TERMINATED